These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 25598421

  • 81. Silencing of the tumor suppressor gene WNK2 is associated with upregulation of MMP2 and JNK in gliomas.
    Costa AM, Pinto F, Martinho O, Oliveira MJ, Jordan P, Reis RM.
    Oncotarget; 2015 Jan 30; 6(3):1422-34. PubMed ID: 25596741
    [Abstract] [Full Text] [Related]

  • 82. Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype.
    Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H, Li W, Hu B, Cheng SY, Li M.
    Cancer Res; 2013 Jan 15; 73(2):990-9. PubMed ID: 23204229
    [Abstract] [Full Text] [Related]

  • 83. Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment.
    Schuster JM, Longo M, Nelson PS.
    J Neurooncol; 2003 Sep 15; 64(3):219-25. PubMed ID: 14558597
    [Abstract] [Full Text] [Related]

  • 84. Site specific hypermethylation of CpGs in Connexin genes 30, 26 and 43 in different grades of glioma and attenuated levels of their mRNAs.
    J J, Vanisree AJ, Ravisankar S, K R.
    Int J Neurosci; 2019 Mar 15; 129(3):273-282. PubMed ID: 30280947
    [Abstract] [Full Text] [Related]

  • 85. MicroRNA218 inhibits glioma migration and invasion via inhibiting glioma-associated oncogene homolog 1 expression at N terminus.
    Peng B, Li D, Qin M, Luo D, Zhang X, Zhao H, Hu S.
    Tumour Biol; 2014 Apr 15; 35(4):3831-7. PubMed ID: 24357514
    [Abstract] [Full Text] [Related]

  • 86. IRF7 promotes glioma cell invasion by inhibiting AGO2 expression.
    Kim JK, Jin X, Ham SW, Lee SY, Seo S, Kim SC, Kim SH, Kim H.
    Tumour Biol; 2015 Jul 15; 36(7):5561-9. PubMed ID: 25680411
    [Abstract] [Full Text] [Related]

  • 87. Silencing of CtBP1 suppresses the migration in human glioma cells.
    Zhao C, Shen Y, Tao X, Xu J, Lu J, Liu C, Xu Z, Tang Q, Tao T, Zhang X.
    J Mol Histol; 2016 Jun 15; 47(3):297-304. PubMed ID: 27160109
    [Abstract] [Full Text] [Related]

  • 88. Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma.
    Hu H, Wang Z, Li M, Zeng F, Wang K, Huang R, Wang H, Yang F, Liang T, Huang H, Jiang T.
    Sci Rep; 2017 Sep 14; 7(1):11568. PubMed ID: 28912488
    [Abstract] [Full Text] [Related]

  • 89. CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression.
    Zhang Q, Yi DY, Xue BZ, Wen WW, Lu YP, Abdelmaksou A, Sun MX, Yuan DT, Zhao HY, Xiong NX, Xiang W, Fu P.
    Cell Death Dis; 2018 Oct 27; 9(11):1101. PubMed ID: 30368520
    [Abstract] [Full Text] [Related]

  • 90. Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma.
    Yang Z, Liu X, Xu H, Teschendorff AE, Xu L, Li J, Fu M, Liu J, Zhou H, Wang Y, Zhang L, He Y, Lv K, Yang H.
    Commun Biol; 2024 Jul 06; 7(1):824. PubMed ID: 38971948
    [Abstract] [Full Text] [Related]

  • 91. Synergism of HPV and MNNG repress miR-218 promoting Het-1A cell malignant transformation by targeting GAB2.
    Zhang Y, Zheng Y, Pan E, Zhao C, Zhang H, Liu R, Wang S, Pu Y, Yin L.
    Toxicology; 2021 Jan 15; 447():152635. PubMed ID: 33189795
    [Abstract] [Full Text] [Related]

  • 92. Developmentally regulated signaling pathways in glioma invasion.
    Mehta S, Lo Cascio C.
    Cell Mol Life Sci; 2018 Feb 15; 75(3):385-402. PubMed ID: 28821904
    [Abstract] [Full Text] [Related]

  • 93. Targeted delivery of miR125a-5p and human Factor VIII attenuates molecular mediators of hemophilic arthropathy.
    Senthilkumar MB, Sarangi P, Amit S, Senguttuvan S, Kumar N, Jayandharan GR.
    Thromb Res; 2023 Nov 15; 231():8-16. PubMed ID: 37741049
    [Abstract] [Full Text] [Related]

  • 94. Increased age of transformed mouse neural progenitor/stem cells recapitulates age-dependent clinical features of human glioma malignancy.
    Mikheev AM, Ramakrishna R, Stoll EA, Mikheeva SA, Beyer RP, Plotnik DA, Schwartz JL, Rockhill JK, Silber JR, Born DE, Kosai Y, Horner PJ, Rostomily RC.
    Aging Cell; 2012 Dec 15; 11(6):1027-35. PubMed ID: 22958206
    [Abstract] [Full Text] [Related]

  • 95. Role of MicroRNAs in Malignant Glioma.
    Wang BC, Ma J.
    Chin Med J (Engl); 2015 May 05; 128(9):1238-44. PubMed ID: 25947409
    [Abstract] [Full Text] [Related]

  • 96. HMGB1 contributes to SASH1 methylation to attenuate astrocyte adhesion.
    Wu R, Yan Y, Ma C, Chen H, Dong Z, Wang Y, Liu Y, Liu M, Yang L.
    Cell Death Dis; 2019 May 28; 10(6):417. PubMed ID: 31138780
    [Abstract] [Full Text] [Related]

  • 97. Role of the microRNA 181 family in glioma development.
    Yang L, Ma Y, Xin Y, Han R, Li R, Hao X.
    Mol Med Rep; 2018 Jan 28; 17(1):322-329. PubMed ID: 29115595
    [Abstract] [Full Text] [Related]

  • 98. Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.
    Dabrowski MJ, Draminski M, Diamanti K, Stepniak K, Mozolewska MA, Teisseyre P, Koronacki J, Komorowski J, Kaminska B, Wojtas B.
    Sci Rep; 2018 Mar 13; 8(1):4390. PubMed ID: 29535343
    [Abstract] [Full Text] [Related]

  • 99. Roles of microRNAs during glioma tumorigenesis and progression.
    Wang S, Yin Y, Liu S.
    Histol Histopathol; 2019 Mar 13; 34(3):213-222. PubMed ID: 30215456
    [Abstract] [Full Text] [Related]

  • 100. "Smad"eningly erratic: target gene methylation determines whether TGFbeta promotes or suppresses malignant glioma.
    Kesari S, Jackson-Grusby L, Stiles CD.
    Dev Cell; 2007 Mar 13; 12(3):324-5. PubMed ID: 17336898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.